Scholarlink

Purpose <p>Severe fever with thrombocytopenia syndrome (SFTS) is an acute infectious disease with rapid progression and high mortality. This study aimed to assess the predictive power of serum neutrophil gelatinase-associated lipocalin (NGAL) for mortality risk and elucidate its cellular origin at the single-cell level.</p> Methods <p>In this retrospective multicenter study, we analyzed clinical data from 215 SFTS patients across three Chinese hospitals (152 in the training cohort and 63 in the external validation cohort). We further analyzed publicly available single-cell RNA sequencing (scRNA-seq) data of peripheral blood mononuclear cells (PBMCs) from SFTS patients and healthy controls to investigate the cellular source of NGAL.</p> Results <p>Serum NGAL was identified as an independent risk factor for 14-day and 28-day all-cause mortality (<i>P</i> &lt; 0.05). High NGAL levels were linearly associated with increased mortality and remained stable across various clinical subgroups. Crucially, unbiased scRNA-seq analysis revealed that the elevated NGAL (encoded by the LCN2 gene) primarily originated from low-density neutrophils (LDNs) that co-purified with PBMCs. These LCN2-expressing LDNs were highly enriched in non-survivors and exhibited a hyper-inflammatory, interferon-stimulated transcriptomic signature.</p> Conclusion <p>Our findings establish serum NGAL as a robust early predictor of mortality risk in SFTS patients, with its elevation intrinsically linked to the pathogenic emergence of highly activated LDNs, providing novel insights into the immunopathology of fatal SFTS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hyper-activated low-density neutrophil-derived NGAL predicts fatal SFTS: a multi-cohort and single-cell study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月1日

查看全文
  • Guangqi Zhu,
  • Zhuolin Han,
  • Bei Jia,
  • Yi Zhang,
  • Yali Xiong,
  • SuKun Kai,
  • Jie Wang,
  • Lifen Hu,
  • Jihua Xue,
  • Chao Wu,
  • Jie Li,
  • Wei Wu

摘要

Purpose

Severe fever with thrombocytopenia syndrome (SFTS) is an acute infectious disease with rapid progression and high mortality. This study aimed to assess the predictive power of serum neutrophil gelatinase-associated lipocalin (NGAL) for mortality risk and elucidate its cellular origin at the single-cell level.

Methods

In this retrospective multicenter study, we analyzed clinical data from 215 SFTS patients across three Chinese hospitals (152 in the training cohort and 63 in the external validation cohort). We further analyzed publicly available single-cell RNA sequencing (scRNA-seq) data of peripheral blood mononuclear cells (PBMCs) from SFTS patients and healthy controls to investigate the cellular source of NGAL.

Results

Serum NGAL was identified as an independent risk factor for 14-day and 28-day all-cause mortality (P < 0.05). High NGAL levels were linearly associated with increased mortality and remained stable across various clinical subgroups. Crucially, unbiased scRNA-seq analysis revealed that the elevated NGAL (encoded by the LCN2 gene) primarily originated from low-density neutrophils (LDNs) that co-purified with PBMCs. These LCN2-expressing LDNs were highly enriched in non-survivors and exhibited a hyper-inflammatory, interferon-stimulated transcriptomic signature.

Conclusion

Our findings establish serum NGAL as a robust early predictor of mortality risk in SFTS patients, with its elevation intrinsically linked to the pathogenic emergence of highly activated LDNs, providing novel insights into the immunopathology of fatal SFTS.